secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001683168-23-004985
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech postpones special meeting to Aug 31; adopts bylaw amendment
------------------------------------------------------------------------------

- Bylaw amendment allows board to fix record date for adjourned meetings under Nevada law.
- Special meeting postponed from July 7 to August 31, 2023 to accommodate a new shareholder proposal.
- Location and record date for the special meeting remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823004985/0001683168-23-004985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823004985/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-004985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer